2269 [177Lu-DOTA]-D-Phe1-Tyr3-octreotide (177Lu-DOTATOC) for peptide receptor radiotherapy in patients with advanced neuroendocrine tumours: A retrospective phase II study of efficacy and safety

2015 ◽  
Vol 51 ◽  
pp. S422-S423
Author(s):  
R.P. Baum ◽  
A.K. Kluge ◽  
H.R. Kulkarni ◽  
M. Sayeg ◽  
U. Schorr-Neufing ◽  
...  
Keyword(s):  
Phase Ii ◽  
Neuroendocrine Tumours ◽  
Phase Ii Study ◽  
Efficacy And Safety ◽  
Peptide Receptor

scholarly journals [177Lu-DOTA]0-D-Phe1-Tyr3-Octreotide (177Lu-DOTATOC) For Peptide Receptor Radiotherapy in Patients with Advanced Neuroendocrine Tumours: A Phase-II Study

Theranostics ◽  
2016 ◽  
Vol 6 (4) ◽  
pp. 501-510 ◽  
Author(s):  
Richard P. Baum ◽  
Andreas W. Kluge ◽  
Harshad Kulkarni ◽  
Ulrike Schorr-Neufing ◽  
Karin Niepsch ◽  
...  
Keyword(s):  
Phase Ii ◽  
Neuroendocrine Tumours ◽  
Phase Ii Study ◽  
Peptide Receptor

scholarly journals Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study

2018 ◽  
Vol 105 ◽  
pp. 114-126 ◽  
Author(s):  
Kenjiro Namikawa ◽  
Yoshio Kiyohara ◽  
Tatsuya Takenouchi ◽  
Hisashi Uhara ◽  
Hiroshi Uchi ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Japanese Patients ◽  
Advanced Melanoma ◽  
Efficacy And Safety ◽  
Open Label ◽  
Multicentre Phase

Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy

2010 ◽  
Vol 123 (3) ◽  
pp. 837-842 ◽  
Author(s):  
Phuong K. Morrow ◽  
Stephen Divers ◽  
Louise Provencher ◽  
Shiuh-Wen Luoh ◽  
Teresa M. Petrella ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Efficacy And Safety

scholarly journals Efficacy and Safety of Multiple Doses of Imab362 in Patients with Advanced Gastro-Esophageal Cancer: Results of a Phase Ii Study

2014 ◽  
Vol 25 ◽  
pp. iv218 ◽  
Author(s):  
T. Trarbach ◽  
M. Schuler ◽  
Z. Zvirbule ◽  
F. Lordick ◽  
A. Krilova ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Efficacy And Safety ◽  
Multiple Doses

scholarly journals A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma

2011 ◽  
Vol 13 (4) ◽  
pp. 437-446 ◽  
Author(s):  
P. Y. Wen ◽  
D. Schiff ◽  
T. F. Cloughesy ◽  
J. J. Raizer ◽  
J. Laterra ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Recurrent Glioblastoma ◽  
Efficacy And Safety
Sign in / Sign up

Export Citation Format

Share Document